File Name,Company Name
Zehna Corporate Deck SymBiosis,Group 2
PS_TCRR_NOTE_1.5.23,"Therapeutics, Inc"
Grace Sciece Platform (9.2.20),Spending & Cash Balance
AcuamarkDx Series A_Corp Deck,AcuamarkDx Inc
coding.bio_deck,DomainCoding
Centurion_BioPharma-Non-Confidential_2021_2,TheBrown Group
JPM_SRZN_NOTE_11.28.22,JPM SE
G_ACET_IOC_4.8.21,ACET
C_ARQT_NOTE_11.15.22,LLC
B_RXRX_IOC_9.21.21,Berenberg Capital Markets
Dianomi Non-Confidential Slides - v3,DianomiTherapeutics
KBC_MAAT.FR_IOC_12.14.21,KBC Securities NV (Belgium)
Engrail Therapeutics,Anhedonia
WB_VOR_IOC_1.25.22,Therapeutics
E_FNCH_IOC_8.10.21,BiomedTrackerDrug Co
CG_GRNA_IOC_12.8.22,GreenLight Biosciences Holdings
LT_AVXL_NOTE_6.22.21,Federal Deposit Insurance Company
LT_PHGE_IOC_4.15.21,Takeda
Graviton Corporate Presentation July 2022,Graviton Holding Company
Bectas Tx Non-Con - Aug.1.2022,Bectas Therapeutics
20 080822_PRTA_Research Summary,"Overview  
Corporate Summary"
CT one-pager Dec 22,circadiantherapeutics. com
221003_PRE_Numab Non-Confidential Presentation,Investment Thesis
2022-3-18 Apeximmune non-confidential Baird,SIRPainteraction on macrophages
Alto Overview_April 2022,"MDD
PTSD
MDD"
[NON-NDA] Integral Overview,"Disclaimer 
Integral"
JMP_NXTC_IOC_5.26.20,NextCure
Flare Non-Con Deck November 2022,"Company Building
NON-CONFIDENTIAL"
AscelpiX Corporate Presentation NON CONFIDENTIAL Feb 8 2022,"Xontogeny
PXV Fund"
